Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP557327.RAbo4twBnLzEFgW4FIQU5pqw88iHZJUEEolCTKSo0c-RM130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557327.RAbo4twBnLzEFgW4FIQU5pqw88iHZJUEEolCTKSo0c-RM130_provenance.
• NP541687.RAYP-wYjQGwH7T0MKCE4RyUCsMWlUJmCILtZTtE1HYIQ0130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541687.RAYP-wYjQGwH7T0MKCE4RyUCsMWlUJmCILtZTtE1HYIQ0130_provenance.
• NP681792.RAbsBmFPCW1Q-s5F_HtoH7akk4A5CLkUfR153ixsRXB4o130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681792.RAbsBmFPCW1Q-s5F_HtoH7akk4A5CLkUfR153ixsRXB4o130_provenance.
• assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP973749.RAdoUVl-EWXtbdKRFPAmOd-g1TV612ahUrvfkCXqG1h7o130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973749.RAdoUVl-EWXtbdKRFPAmOd-g1TV612ahUrvfkCXqG1h7o130_provenance.
• NP973758.RAZElgre-HE0JOSh3IUT2GaYHs-f3m7p9Q_5t2E4zu4cA130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973758.RAZElgre-HE0JOSh3IUT2GaYHs-f3m7p9Q_5t2E4zu4cA130_provenance.
• NP557412.RAv8XppyIVYTmxU_dn_b4jFP_uEpnqC3QIVhkb5lidQQs130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557412.RAv8XppyIVYTmxU_dn_b4jFP_uEpnqC3QIVhkb5lidQQs130_provenance.
• NP973751.RAANWWPuDs1tJ-o66jVP3ES31GG6j94EDCYfVn5DaDxeE130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973751.RAANWWPuDs1tJ-o66jVP3ES31GG6j94EDCYfVn5DaDxeE130_provenance.
• NP973756.RADmIoSf0YYZsiKPknioaMBp2BTB1ep60FljOv838tOwo130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973756.RADmIoSf0YYZsiKPknioaMBp2BTB1ep60FljOv838tOwo130_provenance.
• NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_provenance.
• NP541700.RAE5BMetUQUmacaTYlSQkfUl42LW4ZBSil4kceofvWNiQ130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541700.RAE5BMetUQUmacaTYlSQkfUl42LW4ZBSil4kceofvWNiQ130_provenance.
• NP557426.RAHbxhpMEy1Jk96ieqXS9dJcd3k7t80_g3JHXcI26-qhQ130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557426.RAHbxhpMEy1Jk96ieqXS9dJcd3k7t80_g3JHXcI26-qhQ130_provenance.
• NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_provenance.
• NP681774.RAIekhSGpRmMrliHfjgHhvO-5PHfncOaOfivLWJ4hqjYc130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681774.RAIekhSGpRmMrliHfjgHhvO-5PHfncOaOfivLWJ4hqjYc130_provenance.
• NP973757.RAHyp5z-_fQwar4N23USGEIc0xuh47SsfGCiyVHQU6e-w130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973757.RAHyp5z-_fQwar4N23USGEIc0xuh47SsfGCiyVHQU6e-w130_provenance.
• NP681692.RA-vJI5kyJeuxRdzHJ4bIjhnLhudLmW29mRtT_gcUZELU130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681692.RA-vJI5kyJeuxRdzHJ4bIjhnLhudLmW29mRtT_gcUZELU130_provenance.
• NP973747.RA5q3pZXtPx1zdShU8BPIY7UynG1FLB4SpFB_qUEShqWE130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973747.RA5q3pZXtPx1zdShU8BPIY7UynG1FLB4SpFB_qUEShqWE130_provenance.
• NP973753.RA-obIsWXkUjqBqoZOxz50r0adcHzGQUiQvfMyXE1tdW8130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973753.RA-obIsWXkUjqBqoZOxz50r0adcHzGQUiQvfMyXE1tdW8130_provenance.
• NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973759.RA63FRskE1JlUFnGo3-fFCgemNyP6a1WFoWUExWj5vSn8130_provenance.